Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Adding Aldosterone Receptor Blocker to Dual Renin-Angiotensin-Aldosterone System Blockade on Proteinuria

NCT00528385 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.

NCT NCT00528385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00528385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Adding Aldosterone Receptor Blocker to Dual Renin-Angiotensin-Aldosterone System Blockade on Proteinuria
Lead sponsor
Medical University of Gdansk
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, proteinuria